Naltrexone Starting Dose for Adults
For opioid use disorder, start naltrexone at 25 mg on day 1, then advance to 50 mg daily if no withdrawal signs occur; for alcohol use disorder, start directly at 50 mg daily. 1
Opioid Use Disorder
Initial dosing must be cautious to avoid precipitated withdrawal. The FDA-approved protocol begins with 25 mg on the first day 1. If the patient tolerates this test dose without withdrawal symptoms, advance to the maintenance dose of 50 mg daily starting day 2.
Critical Pre-Treatment Requirements
Before initiating naltrexone for opioid use disorder:
- Patients must be opioid-free for 7-10 days minimum for short-acting opioids 1
- Patients transitioning from buprenorphine or methadone may require up to 2 weeks opioid-free due to prolonged withdrawal risk 1
- Perform a naloxone challenge test if there is any uncertainty about opioid-free status 1
Common Pitfall: Precipitated Withdrawal
The most serious risk is precipitated withdrawal in patients with residual opioid dependence. This manifests as severe nausea, vomiting, dysphoria, sweating, craving, abdominal cramps, muscle aches, pupillary dilation, and vital sign changes 1. If withdrawal signs appear after the 25 mg test dose, do not continue naltrexone—wait 24 hours and reassess 1.
Alcohol Use Disorder
For alcohol use disorder, initiate directly at 50 mg once daily 1. No dose titration is required since these patients are not opioid-dependent. This dosing regimen was validated in placebo-controlled trials demonstrating efficacy for up to 12 weeks 1. Recent evidence supports this approach, with a 2025 emergency department study successfully using a single 50 mg dose followed by a 14-day starter pack 2.
Alternative Dosing Schedules
For supervised administration programs where daily dosing is impractical, flexible regimens are acceptable 1:
- 50 mg on weekdays with 100 mg on Saturday
- 100 mg every other day
- 150 mg every third day
However, single doses above 50 mg carry higher hepatocellular injury risk, so these extended intervals should only be used when the benefits clearly outweigh risks 1.
Special Populations
Hepatic Impairment
While historically avoided, recent evidence indicates naltrexone is safe even in severe alcohol-associated cirrhosis 3. For patients with moderate to severe hepatic impairment receiving naltrexone-bupropion combination therapy, limit to 1 tablet daily 4.
Renal Impairment
For naltrexone-bupropion combination: reduce to 1 tablet twice daily with moderate to severe renal impairment; avoid in end-stage renal disease 4.
Monitoring and Safety
- Baseline and periodic liver function tests (every 3-6 months) are recommended, particularly given historical concerns about hepatotoxicity at supratherapeutic doses 5
- Patients must understand that naltrexone blocks opioid effects completely—attempting to overcome this blockade with high-dose opioids can be fatal 1
- Naltrexone should be discontinued before any procedure requiring opioid analgesia 4
Context of Use
Naltrexone works best as part of comprehensive addiction treatment including behavioral therapy, psychosocial support, and compliance-enhancing strategies 5, 1. The medication decreases alcohol craving and blocks opioid euphoria, but success depends heavily on patient motivation and support systems 5, 6.
The 50 mg daily maintenance dose provides adequate opioid receptor blockade for both indications 1. The key distinction is whether to use the 25 mg test dose first (opioid use disorder) or start directly at 50 mg (alcohol use disorder).